Leprosy (Hansen's Disease): Symptoms, Diagnosis, Treatment, and Stigma

Leprosy is a chronic infectious disease caused by Mycobacterium leprae, primarily affecting skin, peripheral nerves, and upper respiratory mucosa. Transmission requires prolonged close contact with untreated cases via respiratory droplets.

Clinical Forms (Ridley-Jopling Classification)

  • Tuberculoid (TT): Few hypopigmented, anesthetic patches; strong cell-mediated immunity; low bacillary load.
  • Lepromatous (LL): Diffuse symmetric nodules, infiltration; facial thickening (leonine facies); mucosal involvement; high bacillary load; poor immunity.
  • Borderline (BT, BB, BL): Intermediate, immunologically unstable.
  • Indeterminate: Early, few vague lesions; may progress or resolve.

Diagnosis

  • Clinical exam (sensory loss, nerve thickening).
  • Skin slit smear (acid-fast bacilli).
  • Biopsy (granulomas, nerve invasion).
  • PCR for M. leprae DNA.
  • Serology (anti-PGL-1) – supportive.

Treatment: Multidrug Therapy (MDT) – WHO Standard

  • Paucibacillary (TT/BT): Rifampicin + Dapsone × 6 months.
  • Multibacillary (LL/BL/BB): Rifampicin + Dapsone + Clofazimine × 12 months.

MDT is highly effective, free via WHO, and prevents disability if started early. Resistance is rare.

Key Public Health Points

  • Leprosy is curable.
  • Early treatment prevents nerve damage, deformity, and transmission.
  • Stigma remains a major barrier to care—education and integration are essential.

Folk Medicine - Related Articles